For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Asia-Pacific cardiovascular surgical devices market is anticipated to grow at a CAGR of 8.93% for the forecast years of 2017-2025, increasing its net worth from $9531 million in 2016 to $20652 million by the end of 2025.
Asia-Pacific is touted to be the fastest growing region on account of the improving economic stature of the Asian countries and the implementation of advanced surgical techniques in the healthcare. The market segments include end-users and products. At present, surgeries hold the biggest market share in terms of products.
Johnson and Johnson, Toshiba Medical Systems Corporation, Medtronic Plc, GE Healthcare, Philips Healthcare and Abbott Inc are some of the well-known players in the market.